$20M VSL Pharmaceuticals probiotic class action settlement

VSL Pharmaceuticals has agreed to a $20 million class action settlement to resolve claims it falsely advertised the VSL#3 probiotic as clinically proven to treat certain medical conditions.

The VSL#3 settlement benefits consumers who purchased VSL#3 in the United States between June 1, 2016, and June 19, 2019.

Plaintiffs in the class action lawsuit claim VSL Pharmaceuticals falsely advertised the VSL#3 probiotics as clinically proven to treat certain medical conditions. As a result of this false advertising, consumers allegedly overpaid for the product.

VSL Pharmaceuticals has not admitted any wrongdoing but agreed to a $20 million class action settlement to resolve these allegations.

Under the terms of the class action settlement, class members can receive a cash payment based on the number of units of VSL#3 they purchased.

Class members who do not have proof of purchase can claim one unit of VSL#3 purchased and receive a payment of up to $20.

Class members with proof of purchase can claim up to 40 units of VSL#3 and receive a payment of up to $800. Exact payments will vary depending on the number of units claimed and the number of claims filed with the settlement.

The deadline for exclusion and objection is Oct. 20, 2026.

The final approval hearing for the VSL#3 settlement is scheduled for Jan. 6, 2027.

To receive settlement benefits, class members must submit a valid claim form by Oct. 20, 2026.

Who’s Eligible

The class action settlement benefits consumers who purchased VSL#3 in the United States between June 1, 2016, and June 19, 2019.

Potential Award

Up to $800

Proof of Purchase

Purchase receipts, online receipts or credit card statements

Claim Form

NOTE: If you do not qualify for this settlement do NOT file a claim.

Remember: you are submitting your claim under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim. If you’re unsure if you qualify, please read the FAQ section of the Settlement Administrator’s website to ensure you meet all standards (Top Class Actions is not a Settlement Administrator). If you don’t qualify for this settlement, check out our database of other open class action settlements you may be eligible for.

Claim Form Deadline

10/20/2026

Case Name

Starr v. Pharmaceuticals Inc., Case No. 8:19-cv-02173-LKG, in the U.S. District Court for the District of Maryland

Final Hearing

01/06/2027

Settlement Website

VSL3Lawsuit.com

Claims Administrator

VSL#3 Class Action
c/o Settlement Administrator
1650 Arch Street, Suite 2210
Philadelphia, PA 19103
[email protected]
844-942-4216

Class Counsel

Jeremy W. Schulman
Jeffrey S. Gavenman
HUGHES HUBBARD & REED LLP

Edward F. Haber
Michelle H. Blauner
Ian J. McLoughlin
Patrick J. Vallely
SHAPIRO HABER & URMY LLP

Defense Counsel

Andrew Soukup
Marc Capuano
COVINGTON & BURLING LLP

Turner Broughton
WILLIAMS MULLEN

John H. Beisner
SKADDEN ARPS SLATE MEAGHER AND FLOM LLP